Meloxicam Eg (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which blocks the formation of prostaglandins that mediate inflammation, pain, and fever. This targeted inhibition reduces inflammatory responses while preserving COX‑1 activity that protects the stomach lining.

The appropriate dose of Meloxicam Eg is determined by the prescribing clinician based on the patient’s condition, severity, and overall health. Dosage may vary, and the prescriber will tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

Safety of meloxicam during pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Meloxicam Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloxicam offers a higher selectivity for COX‑2 compared with many traditional NSAIDs, which may result in a lower incidence of gastrointestinal side effects. However, it still carries cardiovascular and renal risks similar to other NSAIDs, and the choice of therapy should be individualized based on patient risk factors.

Meloxicam Eg should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Meloxicam Eg is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce occasional stomach upset. Follow the prescriber’s instructions regarding timing and frequency.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe liver or kidney impairment, and rare hypersensitivity reactions like anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Meloxicam Eg should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated during the third trimester of pregnancy.